Discover Great Companies Discover Great Clients
Popularity  20.1万   |   Followers  268   |   Likes  27   |   Feedback  165 Claim this company

Developing innovative drugs to improve human health

No.129 Minhang District Popularity Ranking Shanghai No.4 GMP Production No.6 Chemistry Pharmaceuticals No.7 Biotechnology Chemistry No.7 Zhong Liu Yao Products No.7 Dan Ke Long Kang Ti Yao Products No.7 Hua He Products Design Compositing No.8 Kang Gan Ran Yao Products No.9 Yao Li Yan Jiu No.11 Fen Zi Sheng Wu Xue No.14 Kang Zhong Liu Yao No.25 Yuan Yan Yao No.25 Xin Yao R&D 企业技术中心 博士后工作站 专利示范企业 省级高新技术企业 市级高新技术企业 高新技术企业
More

Company Overview

  • Nature: Listed Company Size: 500-999 employees Founded: 25年
  • Industry: Pharmaceuticals/Bioengineering
  • Full name: Shanghai Hengrui Pharmaceuticals Co., Ltd.。

Development Stage

  • Ranking: Ranked #4 in Shanghai GMP Production Company by popularity Ranked #6 in Shanghai Chemistry Pharmaceuticals Company by popularity Ranked #7 in Shanghai Biotechnology Chemistry Company by popularity Ranked #7 in Shanghai Zhong Liu Yao Products Company by popularity
  • Honors: 企业技术中心 博士后工作站 According to algorithm
  • Salary: 83.6% of positions earn 15-50K, In 2026 vs last yeardecreased by 25%.。Master's salary: ¥29.5K, Doctorate salary: ¥35.0K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 32.8%, "Other (R&D and Technical)": 29.5%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 29.5%。
  • Recruiting: In 2026 vs 2025decreased by 82%. Demand for highly educated talent: Master's: 4, Doctorate: 1.
  • Requirement: Education: 本科 leads with 50%. Experience: 不限 leads with 45.2%.
  • Region: Distributed across 1 regions, 上海: 82.3%, 苏州: 4.8%, 南京: 3.2%, 杭州: 3.2%.

About the Company

[Summary] Developing innovative drugs to improve human health

Shanghai Hengrui R&D Center was established in May 2004, located at No. 279 Wenjing Road, with a total investment of 200 million yuan, covering an area of 44,000 square meters, with a building area of 26,409.6 square meters, of which the production and testing workshop covers 10,005.6 square meters and the R&D center covers 10,053.53 square meters. It is one of the main R&D bases of Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Shanghai R&D Center is committed to the discovery of innovative drugs, focusing on anti-tumor, endocrine, cardiovascular, central nervous system, and macromolecular biology, covering the entire process of new drug development.

Currently, it undertakes several projects of the National Major New Drug Creation Technology Major Project. It has submitted 46 national patent applications and 33 PCT applications, and has begun to enter 16 countries including the United States, Europe, and Japan. Four innovative class I drugs have received approval for phase I clinical trials in China.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (21 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 12%
  • 2024: Up 39%
  • 2023: Up 14%
  • 2022: Down 77%
Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Campus Recruitment & Advanced Degree Talent Demand
Interns 1 Master's 4 Doctorate 1
Note: How fast is hiring at Shanghai Hengrui Pharmaceuticals Co., Ltd. growing? 2026: 28 openings (down 82%), 2025: 155 openings (up 12%), 2024: 138 openings (up 39%), 2023: 99 openings (up 14%), 2022: 87 openings (down 77%), 2021: 376 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Up 39%
  • 2023: Down 16%
  • 2022: Down 56%
Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Shanghai Hengrui Pharmaceuticals Co., Ltd. growing? Master's recruitment over the years: 2025: 53 openings (flat), 2024: 53 openings (up 39%), 2023: 38 openings (down 16%), 2022: 45 openings (down 56%), 2021: 102 openings. Shanghai Hengrui Pharmaceuticals Co., Ltd. master talent ranking in Shanghai: #962, Shanghai Hengrui Pharmaceuticals Co., Ltd. master salary mostly around 15-50K.

Doctoral Degree Job Demand Analysis

(More)
-79%
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Down 30%
  • 2023: Up 67%
  • 2022: Down 71%
Doctoral Hiring by Year: 2026 — 11 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
No.373
Doctoral Demand Ranking in Shanghai 򀀩
¥20-50K
Doctoral Salary 򀀩
How fast is doctoral hiring at Shanghai Hengrui Pharmaceuticals Co., Ltd. growing? Doctorate recruitment over the years: 2026: 3 openings (down 79%), 2025: 14 openings (flat), 2024: 14 openings (down 30%), 2023: 20 openings (up 67%), 2022: 12 openings (down 71%), 2021: 42 openings. Shanghai Hengrui Pharmaceuticals Co., Ltd. doctorate talent ranking in Shanghai: #373, Shanghai Hengrui Pharmaceuticals Co., Ltd. doctorate salary mostly around 20-50K.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Shanghai Hengrui Pharmaceuticals Co., Ltd.? Based on an analysis of 's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 32.8%, "Other (R&D and Technical)": 29.5%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 29.5%, "Scientific Research": 27.9%, "Computer/Network/Technology": 6.6%, "Agriculture, Forestry and Fishery": 4.9%. For reference only.

— What Are the Salaries Like? (61 records)

Manage
salary range: 4.5K - 50K, 83.6% of roles pay ¥15-50K
Note: salary statistics are based on 61 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Shanghai Hengrui Pharmaceuticals Co., Ltd.?83.6% of positions earn 15-50K, Undergraduate salary: ¥。Shanghai salary ranking top 30,销售类 average salary ¥19.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Shanghai Hengrui Pharmaceuticals Co., Ltd.? We provide: Researcher, Information, Pharmaceutical Sales Representative, Writer, Regional Manager, Antibody Discovery, Project Lead, Product Manager, Analyst, 精益主管, Translational Medicine Specialist, Operations, Sales, CRC, QC, 临床, Coordinator, Intern, Marketing, Patient Education Specialist. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Job Category

  • 销售类
    43.5% of total 43.5%
  • 医疗卫生/美容保健类
    32.3% of total 32.3%
  • 其他(研发和技术类)
    29% of total 29%
  • 生物/制药/化工/环保类
    29% of total 29%

Education

  • 本科
    50% of total 50%
  • 硕士
    32.3% of total 32.3%
  • 博士
    9.7% of total 9.7%
  • 大专
    6.5% of total 6.5%

Experience

  • 不限
    45.2% of total 45.2%
  • 3-5年
    30.6% of total 30.6%
  • 1-3年
    22.6% of total 22.6%
  • 5-10年
    1.6% of total 1.6%
View Detailed Analysis

What does Shanghai Hengrui Pharmaceuticals Co., Ltd. require? Who is Shanghai Hengrui Pharmaceuticals Co., Ltd. hiring? recruitment: 销售类占比最多占43.5%,其次是医疗卫生/美容保健类占32.3%. What education can get in at ? 本科占比最多占50%,其次是硕士占32.3%. High education required at ? 硕士占32.3%,博士占9.7%. Work experience required at ? 不限占比最多占45.2%,其次是3-5年占30.6%. Where are the job locations at ? 上海占比最多占82.3%,其次是苏州占4.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 7,200万(元)
Legal Representative: 卢韵
Date Established:
Credit Code: 9131000073336184XW
Registered Address: 上海市闵行区经济技术开发区文井路279号

Partners & Suppliers

2021年,恒瑞医药与璎黎药业达成合作,获得PI3Kδ抑制剂YY-20394在大中华区的独家权益,璎黎药业为技术授权方。 Source
供应商 产品授权/战略合作
泰格医药为恒瑞医药提供临床试验设计、数据管理等临床CRO服务。 Source
供应商 CRO/临床服务
九州通与恒瑞医药在基层医疗市场合作,负责部分药品的配送。 Source
合作客户 医药商业
华润医药是恒瑞医药的药品分销合作伙伴,覆盖华北及全国重点医院。 Source
合作客户 医药商业
康龙化成为恒瑞医药提供药物发现、药代动力学等CRO服务。 Source
供应商 CRO/临床服务

People who follow this company also follow

Competitors (Similar Companies)

“Research, development, and production of anti-tumor and surgical medic”
“In the rapidly growing biopharmaceutical field, accelerate and transfo”
“Continuously innovating to bring patients medicines that significantly”
“To develop high-quality biologics that are accessible and affordable f”
“Promoting human health”
“A leading open-access capability and technology platform company for p”
电机/电动机 压缩机 制冷 制冷设备
木业 地板 实木门 楼梯
电气 连接器 接线端子 研发
印刷/包装 包装材料 生产
机电设备 钢坯 机电 数控/CNC
车身控制系统 后视镜 摄像头 倒车雷达
化妆品 护肤 护肤品 护理用品
液化天然气/LNG 天然气 能源 石油
“Technology-led environmental treatment engineering enterprise”

Discover Great Companies, Discover Great Clients

上海公司名录 上海“Minxing District”公司名录 上海“医药”公司名录 上海“抗肿瘤药”公司名录 上海“创新药”公司名录 上海“化学制药”公司名录 上海“肿瘤药物”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates